To evaluate whether HAb18G/CD147 functionally influences EGFR in pancreatic cancer cells, we performed cell growth assays after exposing cells to CyPA and the EGFR inhibitor gefitinib. This evidence concerns the gene BSG and pancreatic neoplasm.